Optimal time-points for minimal residual disease monitoring change on the basis of the method used in patients with acute myeloid leukemia who underwent allogeneic stem cell transplantation: A comparison between multiparameter flow cytometry and Wilms’ tumor 1 expression

Publication | Closed Access

DOI

Citations

References

2014

Year

Giovanni Rossi, Angelo Michele Carella, Maria Marta Minervini, Francesco Di Nardo, Chiara de Waure, Michele Mario Greco, Emanuela Merla, Giovanni Pio De Cillis, Nicola Di Renzo, Angela Melpignano,

Leukemia Research

Hematological MalignancyTransplantationMedicineAcute Myeloid LeukemiaStem Cell TransplantationHematologyMyeloid NeoplasiaBiostatisticsOptimal Time-pointsRadiation OncologyOncologyCell TransplantationCancer ResearchMinimal Residual DiseaseHealth Sciences